Our Science – Lipkowitz Website
Stanley Lipkowitz, M.D., Ph.D.
Selected Publications |
| 1)
Ryan PE, Kales SC, Yadavalli R, Nau MM, Zhang H, Lipkowitz S. Cbl-c ubiquitin ligase activity is increased via the interaction of its RING finger domain with a LIM domain of the paxillin homolog, Hic 5. PLoS ONE. 7: e49428, 2012. [Journal] |
| 2)
Guo H, Qiao G, Ying H, Li Z, Zhao Y, Liang Y, Yang L, Lipkowitz S, Penninger JM, Langdon WY, Zhang J. E3 Ubiquitin Ligase Cbl-b Regulates Pten via Nedd4 in T Cells Independently of Its Ubiquitin Ligase Activity. Cell Rep. 1: 472-482, 2012. [Journal] |
| 3)
Kales SC, Ryan PE, Lipkowitz S. Cbl exposes its RING finger. Nat. Struct. Mol. Biol. 19: 131-3, 2012. [Journal] |
| 4)
Garimella SV, Rocca A, Lipkowitz S. WEE1 Inhibition Sensitizes Basal Breast Cancer Cells to TRAIL-Induced Apoptosis. Mol. Cancer Res. 10: 75-85, 2012. [Journal] |
| 5)
Lipkowitz S, Weissman AM. RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis. Nat. Rev. Cancer. 11: 629-43, 2011. [Journal] |
| 6)
Chavez KJ, Garimella SV, Lipkowitz S. Triple Negative Breast Cancer Cell Lines: One Tool in the Search for Better Treatment of Triple Negative Breast Cancer. Breast Dis. 32: 35-48, 2011. [Journal] |
| 7)
Yoon HY, Kales SC, Luo R, Lipkowitz S, Randazzo PA. ARAP1 association with CIN85 affects epidermal growth factor receptor endocytic trafficking. Biol. Cell. 103: 171-84, 2011. [Journal] |
| 8)
Ryan PE, Sivadasan-Nair N, Nau MM, Nicholas S, Lipkowitz S. The N-terminus of Cbl-c regulates ubiquitin ligase activity by modulating affinity for the ubiquitin conjugating enzyme. J Biol Chem. 285: 23687-98, 2010. [Journal] |
| 9)
Kales SC, Ryan PE, Nau MM, Lipkowitz S. Cbl and human myeloid neoplasms: the Cbl oncogene comes of age. Cancer Res. 70: 4789-94, 2010. [Journal] |
| 10)
Tan YH, Krishnaswamy S, Nandi S, Kanteti R, Vora S, Onel K, Hasina R, Lo FY, El-Hashani E, Cervantes G, Robinson M, Kales SC, Lipkowitz S, Karrison T, Sattler M, Vokes EE, Wang YC, Salgia R. CBL is frequently altered in lung cancers: its relationship to mutations in MET and EGFR tyrosine kinases. PLoS ONE. 5: e8972, 2010. [Journal] |
| Click Here to View Expanded Bibliography. |
This page was last updated on 4/18/2013.
